Skip to Content

Prolastin (alpha 1-proteinase inhibitor) Disease Interactions

There is 1 disease interaction with Prolastin (alpha 1-proteinase inhibitor):

Major

Alpha 1- proteinase inhibitor

Severe Potential Hazard, Moderate plausibility. Applies to: Immunodeficiency

The use of alpha 1- proteinase inhibitor is contraindicated in immunoglobulin A (IgA) deficient patients with antibodies against IgA, due to the risk of severe hypersensitivity.

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide